Article Sidebar

Submitted
September 20, 2021
Accepted
December 21, 2021
Published
May 24, 2022
Download
PDF
Statistic
Read Counter : 2360 Download : 18332

Downloads

Download data is not yet available.

Main Article Content

Abstract





Sterile products are preparations that meet the physical, chemical requirements and free from microorganisms, both bacteria and fungi. The sterility test is used as one of the parameters for products released from a manufacturer, even though it is not to guarantee entire of the batch meets the sterile requirements. Sterile preparations are manufactured in a facility that has strict environmental characteristics to minimize the risk of microbial contamination. Sterility testing facilities also requires certain facilities to avoid false-positive results, because sterility testing is only be repeated if there is an error in laboratory testing. Sterility test results that give non-sterile results need to be reviewed whether the results obtained are from the product or due to laboratory errors. Sterility testing facilities require large costs. Expensive testing facilities causes the testing are not conducted by all Provincial Laboratory. The regionalized laboratory at Badan POM is a concept to conduct sterility testing that meets national/international guidelines and reduces large costs. This review is based on a literature study covering sterility testing based on national and international guidelines, sterility testing facilities, limitations of sterility testing and investigation of sterility test failure. Additionally, this review will also describe the concept of regionalization of sterility test laboratories at the Indonesian Food and Drug Authority (Indonesian FDA)




 





Keywords

sterility testi sterile regionalized laboratory microbial contamination uji sterilitas, steril, regionalisasi laboratorium, kontaminasi mikroba

Article Details

How to Cite
Setiawati, H., & Lolo Lukita, B. (2022). Regionalisasi Laboratorium Pengujian Sterilitas Badan POM sebagai upaya Efektivitas dan Efisiensi Sumber Daya : Regionalization of the BPOM’s Sterility Testing Laboratory as an Effort for Effectiveness and Efficiency of Resources. Eruditio : Indonesia Journal of Food and Drug Safety, 2(1), 36–46. https://doi.org/10.54384/eruditio.v2i1.96
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Badan Pengawasan Obat dan Makanan. (2013). Petunjuk Operasional Penerapan Cara Pembuatan Obat yang Baik Tahun 2012 Jilid I. ISBN 978-979-3707-78-5 (Jilid I).
  2. Badan Pengawasan Obat dan Makanan. (2018). Peraturan Badan Pengawas Obat dan Makanan Nomor 13 tahun 2018 tentang Penerapan Pedoman Cara Pembuatan Obat yang Baik.
  3. Direktorat Jenderal Kefarmasian dan Alat Kesehatan. (2020). Farmakope Indonesia Edisi VI. Jakarta: Kementerian Kesehatan Republik Indonesia.
  4. European Commission. (2008). EU GMP Annex 1: Manufacture of Sterile Medicinal Products. https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-4/2008_11_25_gmp-an1_en.pdf (diakses pada tanggal 17 September 2021)
  5. European Directorate for the Quality of Medicines & Health Care. (2016). EP Vol. 8.0: Sterility. Strasbourgh: EDQM.
  6. International Organization for Standardization. (2015). ISO 14644-1: Cleanrooms and associated controlled environment – Part 1: Classification of air cleanliness by particle concentration.
  7. Jimenez, L. (2007). Microbial diversity in pharmaceutical product recalls and environments. PDA Journal of Pharmaceutical Science and Technology 61, 383-399.
  8. Jimenez, L. (2019). Analysis of FDA Enforcement Reports (2012-2019) to Determine the Microbial Diversity in Contaminated Non-Sterile and Sterile Drugs. https://www.americanpharmaceuticalreview.com/Featured-Articles/518912-Analysis-of-FDA-Enforcement-Reports-2012-2019-to-Determine-the-Microbial-Diversity-in-Contaminated-Non-Sterile-and-Sterile-Drugs/ (diakses pada tanggal 17 September 2021)
  9. Medicines and Healthcare products Regulatory Agency. (2018). British Pharmacopoeia Volume V: Sterility Testing. London: MHRA.
  10. Ministry of Health, Labour and Welfare. (2016.) Japanese Pharmacopoeia 17th Ed. Sterility Test. Tokyo
  11. Muhvich, K.H. (2015). Successful Sterility Test Failure Investigations - A Practical Approach. https://www.americanpharmaceuticalreview.com/Featured-Articles/173160-Successful-Sterility-Test-Failure-Investigations-A-Practical-Approach/ (diakses pada tanggal 17 September 2021)
  12. Pharmaceutical Inspection Convention. (2007). Recommendation on Sterility Testing. https://picscheme.org/docview/3442
  13. Pharmacopeial Forum. (2017). The development of compendial rapid sterility tests. Article in Pharmacopeial Forum: https://www.researchgate.net/publication/319943401
  14. Sandle, T. (2013). Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals. Woodhead Publishing, pp 3, 8.
  15. Sandle, T. (2014). The Test for Sterility of Medicinal Products. International Journal of Microbiology and Allied Sciences, Vol 1 (1).
  16. Sandle, T. (2015). Investigating Sterility Test Failures. DOI: 10.13140/RG.2.1.2969.9688. https://www.researchgate.net/publication/277141856 (diakses pada tanggal 16 September 2021)
  17. Sandle, T. (2020). How to Investigate Sterility Test Failures. https://www.researchgate.net/publication/342109941
  18. Sutton, S. (2011). Sterility Tests: Rapid Sterility Testing J. Moldenhauer (ed) PDA/DHI Publ pp 7-24 http://microbiologynetwork.com/content/file/sutton_the-sterility-tests.pdf (diakses pada tanggal 17 September 2021)
  19. Sutton, S.W., and L. Jimenez. (2012). A review of reported recalls involving microbiological control 2004-2011 with emphasis on FDA considerations of “Objectionable Organisms”. American Pharmaceutical Review 15, 42-57.
  20. Therapeutic Good Administration (TGA). (2006). Guidelines for sterility testing of therapeutic goods. https://www.tga.gov.au/sites/default/files/manuf-sterility-testing-guidelines.pdf. (diakses pada tanggal 17 September 2021)
  21. United States Pharmacopeial Convention. (2019). USP 42 NF 37 Online: Sterility Testing.
  22. United States Pharmacopeial Convention. (2019). USP 42 NF 37 Online: Pharmaceutical Compounding Sterile Preparations.
  23. U.S. Food and Drug Administration. (2004). Guidance on Sterile Drug Products Produced by Aseptic Processing. https://www.fda.gov/media/71026/download. (diakses pada tanggal 17 September 2021).
  24. World Health Organization. (2011). Annex 6: WHO Good Manufacturing Practices for Sterile Pharmaceutical Products. WHO Technical Report Series, No. 96. https://www.isotechdesign.com/product/pharmaceuticals/sterility-testing/) (diakses pada tanggal 18 September 2021)
  25. https://www.cleanroomtechnology.com/news/article_page/Cleanroom_monitoring_with_image_documentation_for_safe_preparation_of_steriles/129174 (diakses pada tanggal 20 September 2021).